His track record seems smooth if I am not missing anything. This sounds good:
"Mr. Taylor J. Crouch has been Chief Executive Officer and President of Organovo Holdings, Inc. since April 25, 2017. Mr. Crouch served as Chief Executive Officer of eStudySite, Inc. until April 2017. Mr. Crouch has 25 years of drug development and commercialization experience spanning large pharmaceutical companies, biotech and the CRO industry. Mr.Crouch served as Senior Vice President of Operations & Supply Operations and President of International of Ligand Pharmaceuticals Incorporated since May 2005. Prior to joining Ligand in May 2005, Mr. Crouch served as President and Chief Operating Officer of Discovery Partners International Inc. from July 2002 to January 2005. From April 1999 to April 2002, he served as President and Chief Executive Officer of Variagenics Inc. From January 1991 to March 1999, he served as the Senior Vice President of Worldwide Marketing and Strategic Development of PAREXEL International Corp. He held various positions for over ten years with Schering-Plough International and Pfizer. He has been Director of Organovo Holdings, Inc. since April 25, 2017. He served as a Director of Bruker AXS, Inc. since November 2000. He served as an Independent Director of Bruker Corporation from July 2003 to May 16, 2007. From April 1999 to April 2002, he served as a Director of Variagenics, Inc. Mr. Crouch has a B.S. in Chemical Engineering, cum laude, from Princeton University and an M.B.A. in International Finance and Marketing from the University of Chicago."
Variagenics was acquired by another pharma; Ligand is currently trading at $123; Parexel is a life sciences consulting firm, which conducts clinical trials on behalf of their clients to expedite the drug approval process. Apart from these Pfizer and Schering-Plough International are big names.
This what i found...
Do share information I might be missing.
